1-5 of 5
Bridget K. Marcellino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PPM1D inhibition may allow us to WIP leukemia

Bridget K. Marcellino
Journal: Blood
Blood (2023) 142 (24): 2040–2042.
https://doi.org/10.1182/blood.2023021943
Published: 2023
Journal Articles

Characterization of Myeloid Neoplasms in Inflammatory Bowel Disease

Daniel I Nathan, David Mueller, Angela Liu, John Mascarenhas, Bridget K Marcellino
Journal: Blood
Blood (2022) 140 (Supplement 1): 4056–4057.
https://doi.org/10.1182/blood-2022-160476
Published: 2022
Journal Articles

Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis

Bridget K Marcellino, Cara Clementelli, Kristin Beaumont, Christoph Schaniel, Min Lu, Karie Chen, Adena Russel, Ayman Mohammad, Daniel I Nathan, Jake Aronin, Alan H. Shih, Robert Sebra, Ronald Hoffman
Journal: Blood
Blood (2022) 140 (Supplement 1): 797–798.
https://doi.org/10.1182/blood-2022-170232
Published: 2022
Journal Articles

Prognostic Impact of Day 14 Bone Marrow (D14 BM Bx) in Acute Myeloid Leukemia (AML) in the Setting of European Leukemianet (ELN) Risk Classification

Metodi Balev, Nicole Zubizarreta, Erin Bresnahan, Jonathan Feld, Marina Kremyanskaya, Alla Keyzner, Alan H. Shih, Bridget K Marcellino, Lewis R. Silverman, Michal Bar-Natan, John Mascarenhas, Douglas Tremblay
Journal: Blood
Blood (2022) 140 (Supplement 1): 139–140.
https://doi.org/10.1182/blood-2022-167828
Published: 2022
Journal Articles

SLAM dunk for myelofibrosis?

Bridget K. Marcellino, John Mascarenhas
Journal: Blood
Blood (2019) 134 (10): 789–791.
https://doi.org/10.1182/blood.2019002119
Published: 2019